Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE38.3600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots35.0000/ 1
- Ask / Lots50.0000/ 1
- Open / Previous Close0.0000 / 38.3600
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 1394 | 38.87 |
| 09:34 ET | 400 | 38.695 |
| 09:36 ET | 126 | 38.64 |
| 09:39 ET | 200 | 38.42 |
| 09:41 ET | 628 | 38.44 |
| 09:43 ET | 700 | 38.54 |
| 09:45 ET | 207 | 38.62 |
| 09:50 ET | 2093 | 38.76 |
| 09:52 ET | 100 | 38.795 |
| 09:54 ET | 100 | 38.92 |
| 09:56 ET | 1500 | 38.92 |
| 09:57 ET | 600 | 38.8118 |
| 09:59 ET | 100 | 38.96 |
| 10:06 ET | 1781 | 38.815 |
| 10:14 ET | 200 | 38.76 |
| 10:15 ET | 843 | 38.65 |
| 10:17 ET | 636 | 38.54 |
| 10:19 ET | 200 | 38.57 |
| 10:28 ET | 500 | 38.48 |
| 10:32 ET | 900 | 38.5475 |
| 10:42 ET | 387 | 38.6 |
| 10:46 ET | 400 | 38.67 |
| 10:48 ET | 1480 | 38.625 |
| 10:53 ET | 100 | 38.59 |
| 10:55 ET | 500 | 38.6475 |
| 11:00 ET | 200 | 38.6 |
| 11:02 ET | 100 | 38.57 |
| 11:04 ET | 100 | 38.57 |
| 11:13 ET | 100 | 38.67 |
| 11:18 ET | 600 | 38.6 |
| 11:20 ET | 300 | 38.62 |
| 11:22 ET | 202 | 38.635 |
| 11:24 ET | 100 | 38.71 |
| 11:33 ET | 3400 | 38.39 |
| 11:38 ET | 300 | 38.415 |
| 11:40 ET | 100 | 38.43 |
| 11:42 ET | 100 | 38.44 |
| 11:44 ET | 100 | 38.42 |
| 11:45 ET | 200 | 38.45 |
| 11:47 ET | 1333 | 38.39 |
| 11:49 ET | 100 | 38.31 |
| 11:51 ET | 300 | 38.29 |
| 11:54 ET | 200 | 38.25 |
| 11:56 ET | 1452 | 38.335 |
| 11:58 ET | 262 | 38.335 |
| 12:00 ET | 100 | 38.345 |
| 12:02 ET | 200 | 38.355 |
| 12:03 ET | 620 | 38.42 |
| 12:05 ET | 12471 | 38.245 |
| 12:07 ET | 1710 | 38.3 |
| 12:09 ET | 2499 | 38.33 |
| 12:16 ET | 200 | 38.395 |
| 12:18 ET | 500 | 38.38 |
| 12:20 ET | 4589 | 38.36 |
| 12:21 ET | 388 | 38.36 |
| 12:23 ET | 840 | 38.355 |
| 12:25 ET | 2700 | 38.315 |
| 12:27 ET | 8931 | 38.32 |
| 12:30 ET | 2440 | 38.22 |
| 12:32 ET | 300 | 38.24 |
| 12:34 ET | 136 | 38.2 |
| 12:36 ET | 200 | 38.24 |
| 12:39 ET | 200 | 38.315 |
| 12:41 ET | 3750 | 38.26 |
| 12:45 ET | 800 | 38.395 |
| 12:48 ET | 300 | 38.375 |
| 12:52 ET | 100 | 38.395 |
| 12:54 ET | 1571 | 38.405 |
| 12:56 ET | 200 | 38.395 |
| 12:57 ET | 400 | 38.41 |
| 12:59 ET | 1735 | 38.295 |
| 01:01 ET | 1000 | 38.25 |
| 01:03 ET | 1675 | 38.28 |
| 01:06 ET | 3805 | 38.25 |
| 01:08 ET | 820 | 38.21 |
| 01:14 ET | 100 | 38.27 |
| 01:17 ET | 300 | 38.25 |
| 01:19 ET | 536 | 38.26 |
| 01:24 ET | 187 | 38.265 |
| 01:26 ET | 100 | 38.34 |
| 01:28 ET | 1413 | 38.37 |
| 01:30 ET | 4226 | 38.26 |
| 01:32 ET | 600 | 38.11 |
| 01:33 ET | 4374 | 38.04 |
| 01:35 ET | 300 | 38.055 |
| 01:37 ET | 200 | 38.085 |
| 01:39 ET | 600 | 38.02 |
| 01:44 ET | 600 | 38.005 |
| 01:46 ET | 665 | 37.955 |
| 01:48 ET | 2400 | 38 |
| 01:51 ET | 300 | 38.03 |
| 01:53 ET | 100 | 38.1 |
| 01:57 ET | 100 | 38.075 |
| 02:00 ET | 200 | 38.07 |
| 02:02 ET | 1300 | 38.15 |
| 02:04 ET | 2002 | 38.29 |
| 02:06 ET | 500 | 38.33 |
| 02:08 ET | 800 | 38.32 |
| 02:09 ET | 100 | 38.325 |
| 02:11 ET | 300 | 38.35 |
| 02:13 ET | 1240 | 38.38 |
| 02:15 ET | 316 | 38.45 |
| 02:18 ET | 200 | 38.43 |
| 02:20 ET | 4322 | 38.35 |
| 02:22 ET | 400 | 38.35 |
| 02:24 ET | 100 | 38.34 |
| 02:26 ET | 1089 | 38.2875 |
| 02:27 ET | 100 | 38.28 |
| 02:29 ET | 500 | 38.34 |
| 02:31 ET | 100 | 38.25 |
| 02:33 ET | 691 | 38.35 |
| 02:36 ET | 300 | 38.33 |
| 02:38 ET | 500 | 38.46 |
| 02:40 ET | 100 | 38.36 |
| 02:42 ET | 400 | 38.35 |
| 02:44 ET | 990 | 38.33 |
| 02:47 ET | 975 | 38.305 |
| 02:49 ET | 1081 | 38.34 |
| 02:51 ET | 287 | 38.34 |
| 02:54 ET | 700 | 38.35 |
| 02:56 ET | 1621 | 38.32 |
| 02:58 ET | 1116 | 38.35 |
| 03:00 ET | 487 | 38.41 |
| 03:02 ET | 400 | 38.345 |
| 03:03 ET | 300 | 38.36 |
| 03:05 ET | 689 | 38.33 |
| 03:07 ET | 300 | 38.28 |
| 03:09 ET | 400 | 38.35 |
| 03:12 ET | 100 | 38.355 |
| 03:14 ET | 400 | 38.35 |
| 03:16 ET | 405 | 38.34 |
| 03:18 ET | 435 | 38.36 |
| 03:20 ET | 1000 | 38.33 |
| 03:21 ET | 311 | 38.34 |
| 03:23 ET | 290 | 38.35 |
| 03:25 ET | 1199 | 38.215 |
| 03:27 ET | 1162 | 38.21 |
| 03:30 ET | 971 | 38.11 |
| 03:32 ET | 400 | 38.11 |
| 03:34 ET | 1100 | 38.145 |
| 03:36 ET | 787 | 38.145 |
| 03:38 ET | 2100 | 38.19 |
| 03:39 ET | 300 | 38.145 |
| 03:41 ET | 687 | 38.115 |
| 03:43 ET | 1018 | 38.105 |
| 03:45 ET | 705 | 38.205 |
| 03:48 ET | 603 | 38.2 |
| 03:50 ET | 1417 | 38.25 |
| 03:52 ET | 2136 | 38.35 |
| 03:54 ET | 1500 | 38.37 |
| 03:56 ET | 5884 | 38.425 |
| 03:57 ET | 2968 | 38.425 |
| 03:59 ET | 32877 | 38.36 |
Jun 5, 2024
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:01PM ET on Wednesday Jun 05, 2024 by Dow Jones
4:01PM ET on Wednesday Jun 05, 2024 by Dow Jones
May 28, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 2.9B | -14.1x | --- |
Structure Therapeutics Inc | 2.9B | -22.4x | --- |
SpringWorks Therapeutics Inc | 2.9B | -7.5x | --- |
MoonLake Immunotherapeutics | 2.8B | -57.7x | --- |
Biohaven Ltd | 3.0B | -4.9x | --- |
Geron Corp | 3.0B | -14.7x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- Chairman of the Board
- Simon Pimstone
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.27 |
EPS | $-2.71 |
Book Value | $12.31 |
P/E Ratio | -14.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
